pRRL Luciferase Citations (3)

Originally described in: The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.
Kovalski JR, Bhaduri A, Zehnder AM, Neela PH, Che Y, Wozniak GG, Khavari PA Mol Cell. 2019 Jan 4. pii: S1097-2765(18)31031-1. doi: 10.1016/j.molcel.2018.12.001. PubMed Journal

---

Articles Citing pRRL Luciferase

Articles
HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV. Milewska A, Chi Y, Szczepanski A, Barreto-Duran E, Dabrowska A, Botwina P, Obloza M, Liu K, Liu D, Guo X, Ge Y, Li J, Cui L, Ochman M, Urlik M, Rodziewicz-Motowidlo S, Zhu F, Szczubialka K, Nowakowska M, Pyrc K. J Virol. 2021 Jan 28;95(4). pii: JVI.01622-20. doi: 10.1128/JVI.01622-20. Print 2021 Jan 28. PubMed
Kallikrein 13 serves as a priming protease during infection by the human coronavirus HKU1. Milewska A, Falkowski K, Kulczycka M, Bielecka E, Naskalska A, Mak P, Lesner A, Ochman M, Urlik M, Diamandis E, Prassas I, Potempa J, Kantyka T, Pyrc K. Sci Signal. 2020 Nov 24;13(659). pii: 13/659/eaba9902. doi: 10.1126/scisignal.aba9902. PubMed
Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors. Lv X, Lu X, Cao J, Luo Q, Ding Y, Peng F, Pataer A, Lu D, Han D, Malmberg E, Chan DW, Wang X, Savage SR, Mao S, Yu J, Peng F, Yan L, Meng H, Maneix L, Han Y, Chen Y, Yao W, Chang EC, Catic A, Lin X, Miles G, Huang P, Sun Z, Burt B, Wang H, Wang J, Yao QC, Zhang B, Roth JA, O'Malley BW, Ellis MJ, Rimawi MF, Ying H, Chen X. Science. 2023 Sep 8;381(6662):eabn4180. doi: 10.1126/science.abn4180. Epub 2023 Sep 8. PubMed

If you have published an article using this material, please email us at to have your article added to this page.